Robert Iannone, EVP, Global Head of R&D & CMO at Jazz Pharmaceuticals plc (JAZZ), sold 4,806 shares at $138.41 ($665K) on 2025-03-10, disclosed to the SEC on 2025-03-12.
Seasonal sale ($665k) by EVP, Global Head of R&D & CMO — this insider has traded JAZZ in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.41 | 2,403 | $333K | 50.0% |
| 2 | $138.41 | 2,403 | $333K | 50.0% |
| Total | $138.41 avg | 4,806 | $665K | 100% |
| Filing → |
| JAZZ | SELL | 2025-03-07 | $1.7M | — | Filing → |
| JAZZ | SELL | 2022-12-13 | $559K | — | Filing → |